C&EN7h
FDA approves drug for neurofibromatosis
The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...
JD Supra1d
A Model’s Credibility Is in the Details: FDA Draft Guidance on the Use of AI Models in Drug and Biological Product Development
In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) models in ...
Chemistry World1d
Generative AI pipeline creates promising antimicrobial peptides
A new generative AI model rapidly generates diverse antimicrobial peptide structures for screening against ...
News Medical on MSN11d
3D Model Accurately Mimics the Blood–Brain Barrier
A 3D model has been developed that accurately replicates the complex structures of cerebral blood vessels, enabling ...
News Medical5d
New 3D bioprinted gastric cancer model predicts drug responses
A collaborative research team led by Professor Jinah Jang from the Department of Mechanical Engineering and the Department of ...
Ellipses Pharma Limited: Ellipses In-Licences First in Class Novel Immuno-Oncology Agent With Potential as a Next Generation Checkpoint Inhibitor
Ellipses Pharma Limited ("Ellipses"), a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model, announced today it is ...